Streetbeat News

Products Services

LLY

Eli Lilly and Company (NYSE:LLY) has announced a collaboration with OpenAI to leverage generative AI for the discovery of novel antimicrobials to treat drug-resistant bacteria. This partnership aims to address the significant global health threat posed by antimicrobial resistance (AMR).

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 2:01 pm

XOM

ExxonMobil and EV battery maker SK On have signed a Memorandum of Understanding (MOU) to produce Mobil Lithium in the U.S. This agreement highlights the demand for domestically sourced lithium and marks a significant step in strengthening the U.S. electric vehicle and battery supply chains. The initiative is expected to enhance energy security, support U.S. manufacturing jobs, and reduce carbon emissions.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 2:01 pm

ABBV

AbbVie Inc (NYSE:ABBV) received an FDA Complete Response Letter (CRL) for its Parkinson's disease therapy ABBV-951 due to issues at a third-party manufacturer. The CRL does not cite safety, efficacy, or labeling concerns, nor does it request additional trials. ABBV-951 is already approved in 34 countries. AbbVie's stock was down 0.38% following the news.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 1:58 pm

TGT

Target announced it will reduce prices on approximately 3,500 more items throughout the summer, aiming to attract more customers and boost sales.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:57 pm

VLTLF

Volt Lithium, led by CEO Alex Wylie, is focusing on extracting lithium from oilfield brine, presenting a $6 billion cash flow opportunity. Despite initial market skepticism, the company has secured industry validation and investment to deploy a field unit in Texas. Volt aims to scale up its operations with minimal capex, leveraging existing oil and gas infrastructure.

Portfolio Pulse from Stjepan Kalinic

June 25, 2024 | 1:57 pm

HJEN

HYDR

PLUG

Plug Power, Inc. (NASDAQ:PLUG) announced it has exceeded 7.5 gigawatts in global Basic Engineering and Design Package (BEDP) contracts within two years. Despite this achievement, PLUG stock has lost over 73% in the past year. Investors can gain exposure to the stock via Global X Hydrogen ETF (NASDAQ:HYDR) and Direxion Hydrogen ETF (NYSE:HJEN). Plug Power also secured industry certification for its high-powered stationary system and a 25 MW order for PEM electrolyzer systems for a European customer.

Portfolio Pulse from Nabaparna Bhattacharya

June 25, 2024 | 1:57 pm

AZN

AstraZeneca's cancer drug Imfinzi failed to meet the primary endpoint in a Phase 3 trial for early-stage lung cancer but succeeded in a Phase 3 bladder cancer study. The drug showed no new safety concerns and is being investigated in other lung cancer settings. Japan also approved AstraZeneca's Tagrisso for a specific type of lung cancer.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 1:45 pm

KSCP

Knightscope announced that two more clients have renewed their contracts for the K5 security robots. This indicates continued trust and satisfaction with Knightscope's services.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:39 pm

WVE

Wave Life Sciences Ltd (NASDAQ:WVE) announced positive results from its Phase 1b/2a SELECT-HD trial of WVE-003 for Huntington’s disease. The trial showed significant lowering of mutant huntingtin protein and preservation of healthy huntingtin protein, with no serious adverse events reported. Despite the positive results, WVE shares traded down 3.07% to $5.05.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 1:37 pm

RTX

WLFC

Willis Lease Finance Corporation (WLFC) has entered into an agreement with Pratt & Whitney, a division of RTX Corporation, to purchase up to 15 new engines in FY24. The transaction is valued at $363.9 million.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:35 pm